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EDWARD H. FERGUSON, M.D. AND WILLIAM L. EPSTEIN, M.D.
Vascular changes undoubtedly play a signifi-
cant role in the pathogenesis of psoriasis. The
present study concerns the local hemodynamics
of psoriatic plaques measured by skin clearance
of radioactive substances. This method gives a
rough measure of local vascular dynamics (1—7),
and, despite any shortcomings, probably supplies
a more realistic picture than does use of color-
imetry or plethysmography (3).
MATERIALS AND METHODS
Fourteen patients with psoriasis, ranging in
age from 18 to 64 years, were examined at rest in
a room temperature environment that did not
vary over 10 F. Each subject served as his own
control. Sixty observations of clearance times
were made from psoriatie plaques and 54 from
control areas. In 26 additional non-psoriatie sub-
jects, clearance times were determined in 65
instances following injection of pharmacologic
agents such as histamine, Histalog (8) and 48:80;
52 control readings were made in this group.
Iodine131 as sodium iodide in solution (20 uc/ml.)
was injected intradermally into the center of
small psoriatic plaques and into uninvolved areas
of skin. Each injection contained 0.05 ml. (1 ue).
Radioactivity was detected by means of a sodium
iodide crystal equipped with a flat field collum-
nator attached to a Nuclear-Chicago Ultrascaler,
Model 192 A. The collumnator was placed directly
over the injection wheal in light contact with the
skin. Counts per minute were calculated every
1j4 minutes starting 3 minute after injection.
Most observations were made on the thigh where
results generally were reproducible. Measurements
around joints and in acral areas yielded results
that were variable and generally unsatisfactory.
We avoided lesions on the trunk due to inability
to immobilize test sites. Control test sites were
located near the psoriatic plaque or in an identical
site on the opposite extremity. At least 4 to 6
observations were made on each subject.
The logs of the counts per second were deter-
mined from these data and recorded on semi-log
graph paper; the result was a straight line. The
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time in minutes after injection for the counts to
fall to one-half the initial reading was designated
T j-. It reflects the rate of clearance (3).
RESULTS
1131 invariably disappeared from acute or
chronic psoriatic plaques more rapidly than from
uninvolved skin. An example of the pattern of
clearance is shown in Fig. 1. In this instance the
T 3 for the psoriatic lesion (2.9 mm.) was about
one-third that for uninvolved skin (9.2 mm.).
The average clearance rates for all active psori-
atic plaques and their controls are compared in
Table I. The average difference between the T 3
times of controls and plaques (6.9 mm.) indicates
the marked change in hemodynamics of the
psoriatic lesion. In a situation where the T !%
from uninvolved skin averages 10.7 mm., this
becomes a highly significant measurement. On
the other hand, clearance rates from uninvolved
skin of psoriatic patients followed the same pat-
tern as they did in normal subjects. The T j
from wheals produced by injections of histamine,
histalog or 48:80 showed a slight, probably in-
significant, decrease over control readings
(Table II). The increased clearance from ultra-
violet light-induced erythema and from lesions of
erythema multiforme was not of the same order
as that seen in psoriasis. No patients with general-
ized seborrheic dermatitis were tested.
The question of possible lateral spread was
tested by means of autoradiographs taken over
injection sites. I' (100 uc/0.05 cc.), was injected
as before into normal skin and into psoriatic
plaques. Then unexposed dental film was applied
to the skin surface, protected by a thin lead
screen to give sharper definition. The film was
changed every two minutes for twelve minutes.
No lateral spread was detected. In fact, the spot
of radioactivity disappeared from the psoriatie
patch after the second film, but remained in all
films over uninvolved control skin.
To test whether or not our findings were unique
for iodine, Na22 as sodium chloride (8 uc/ml.) was
injected into psoriatic plaques and control sites.
The pattern of clearance from both uninvolved
and psoriatic lesions followed that seen with
442 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Lao
COUNTS
SECOND
PSORIASIs vs CG$TRØL
3 L 3 4 6 6 7 6 9 1O a a ts 14
1/DIE IN 11/NOTED 4FTC& INJECTION OP I"
Fta. 1. A comparison of the rate of clearance of
Jill from a psoriatic plaque and control site in the
same patient.
TABLE I
Active plaques
Number
of Com-
T3/i Times in
Minutes
•T¼Times in
Minutes Av-
Site parative
Observa-
tions
Averages erage Differ-
ences Plaques
& Controls
Plaque
Thigh 16 12.7 4.3 8.4
Upper arm 5 7.4 3.5 3.9
Elbow 2 8.2 3.2 5.0
Knee 1 11.5 5.3 6.2
Average of differences = 6.9 minutes.
TABLE II
Average differences of T4 times between
test areas and uninvolved control sites
Test Sites
Number
of Com-
parative
Observa-
tions
DiffeT-
enre in
Minutes
Psoriasis (active plaques)
Histamine Histalog and 48:80
wheals3 hour to 2}z hours after ultra-
violet light
Erythema multiforme drug
eruptions
24
56
3
3
6.9
0.7
1.8
3.4
JtSt Apparently the observations have general
significance in regard to local fluid dynamics.
Involuting psoriatie lesions showed a consistent
prolongation in clearance time. The T Jv times
approached those of uninvolved skin (Table III).
The return toward normal was not conditioned
by the type of therapy; it occurred whenever the
lesions began to heal. The rate of change toward
TABLE III
Involuting and cleared plaques
Site
T½ Times in
Minutes
Number Th Times in
of Com- - Minutes Av-
parative Averages erage Dtffer-Observa- cures Plaques
tions & Controls
Con- Pla-
trol que
Thigh
Upper arm
Knee
11
3
1
9.8
7.0
9.3
8.9
6.2
8.6
0.9
0.8
0.7
Average of differences = 0.9 minutes.
TABLE IV
Differences between T?4 times of controls
and plaques after local injections
of triamcino lone
Time after Inlection Minutes
1 hour
2 days
7 days
9 days
11 months (atrophic area)
6.0*
2.8
3.0
2.3
0.0
* Same as control.
'a,
¼1u
Fja. 2. Differences between T3. times of control
and psoriatie lesion. The fluctuation accurately
portrays the changing clinical status of the lesion.
normal was studied by determining the clearance
times in psoriasis plaques at intervals after the
intralesional injection of triamcinolone (Table
IV). By two days, when the lesion was just be-
ginning to heal, the clearance time had markedly
decreased. During the next seven days—despite
almost complete clinical clearing of the lesion—
no further change was observed in the rate of
Jill clearance. This finding suggests that vascular
Th-
TIME INTERVAL - S MONTHS
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dynamics can be expected to change more rapidly
than epidermal metabolism. The precise time of
return to a completely normal blood flow was not
determined, but by a year the mildly atrophic
injection site responded normally.
Four patients were examined periodically dur-
ing flares and remissions. The fluctuation of skin
clearance correlates well with fluctuations in ac-
tivity of the disease. An example is presented in
Fig. 2. In one instance an increased clearance
rate was noted in a clinically healing lesion.
Within a week the lesion had flared up, suggest-
ing that determination of the T 3 time may have
prognostic value.
DISCUSSION
Despite much excellent work, psoriasis re-
mains a disease of unknown etiology. Even the
primary site of involvement has not been estab-
lished (9, 10). Although some work tends to im-
plicate the epidermis (11), a number of investi-
gators feel the dermis and dermal vasculature
are the nascent sites of the disease (12-14). Un-
questionably the blood vessels play a significant
role in the genesis of psoriasis as a pathologic
entity (10, 15—23). Capillaries are dilated and
tortuous (24—27); the view with a capillary
microscope is characteristic (10, 15, 26, 28, 29).
The changes appear before recognizable epidermal
changes (10) and persist after healing (15). Even
with ordinary histological methods, a persistence
of vascular changes after clinical clearing has
been demonstrated (30, 31). The function of
these vessels, however, has received little atten-
tion. Aside from a delayed onset of reactive
hyperemia in uninvolved skin of psoriatics (32,
33) and some questionable changes in plethysmo-
graphic patterns of digits (34), no functional ab-
normalities have been described. Blood flow
through the digits is reported as normal (35).
Herrmann and Kanof demonstrated a fluorescent
halo surrounding psoriatic lesions after intrave-
nous injection of fluorescein (36). The lesions
themselves remained dark, and although these
workers recognized that a thick scale could mask
fluorescence, they speculated that a sluggish
circulation might also explain the phenomenon.
Our results do not substantiate this view. We
have observed a remarkably rapid disappearance
of J131 from psoriatic lesions. Certainly the
lymphaties play a role in clearing 1131. However,
considering the anatomical findings of vascular
dilatation and the rapidity of clearance, which is
not characteristic of lymph flow, we view the
blood vessels as the major determinant of Jill
clearance in this instance. Blood flow through
psoriatic plaques seems exceedingly rapid, and
this may help explain the high state of metabolic
activity of the lesion (17, 37—39). In healing,
changes in vascular physiology probably precede
epidermal changes.
5UMAIARY
The blood flow in psoriatic plaques is increased
as indicated by an increased clearance rate of
locally injected radioactive salt solutions. This
functional abnormality tends to vanish with in-
volution of the lesion.
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DISCUSSION
DR. EUGENE J. VAN SCOTT (Bethesda, Mary-
land): Your data, of course, does suggest that
there is an increased blood flow through the lesion
of psoriasis. Yet, the epidermis of psoriasis, com-
pared to normal, is several fold thicker than nor-
mal and the thickness of the epidermis may
approach a half millimeter. How does one gauge
the depth to which this material is injected and
how does depth of injection influence the disap-
pearance rate?
DR. PETER FLESCH (Philadelphia, Pennsyl-
vania): Wouldn't the thickness of the epidermis
testing the effect of vasodilation because it also
causes exudation which in its turn compresses the
dilated minute blood vessels. Pure vasodilators
such as acctylcholine or priscolinc could be used
to decide whether pure vasodilation causes such
great increase in clearance as was observed by
the investigators in psoriasis.
DR. EDWARD H. FERGUSON (in closing): I wish
to thank the discussors.
In answer to Dr. Van Scott and Dr. Flesch,
the depth of injection (and particularly in the
thickened psoriasis plaque), does influence the
influence the count? count.
DR. STEPHEN ROTHMAN (Chicago, Illinois): However, what we are doing is comparing the
Histamine is not an appropriate substance for rate of fall off, not the exact counts. This is one
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reason the individual must serve as his own con-
trol. Although it wasn't true in some instances,
usually the count was slightly lower in the
psoriasis plaques.
Now as far as iodine within a skin lesion is con-
cerned, we are injecting JiSi and watching its dis-
appearance, which is a matter of a very short
time. We are talking about it becoming half what
it was in anything from two and a half minutes
to twelve or fifteen minutes, depending upon the
lesion we are dealing with. Total iodine content
and iodine metabolism will have no hearing on
the results. We feel that the clearance is by way
of blood vessels and that this method is a good
rough measure of the effectiveness of the local
circulation. (References 1—7).
As far as Dr. Rothman's question about using
a good vasodilator as a control, I think this is a
very good point.
We did, of course, use epinephrine and like
everyone else who has used this sort of technic,
we got a decrease and, in fact, practically a com-
plete cessation of clearance (References 1 & 2).
Priscoline has been shown to increase the clear-
ance rate. (Freund, J., Wisham, L. H., and
Yalow, H. S.: The Effect of Priseoline on the
Clearance of Radiosodium from Muscle and Skin
of Man in Normal and Diseased Limbs. Circula-
tion. 8: 89, 1953).
We did demonstrate with hyaluronidase that
diffusion could give some increase in disappear-
ance time but it wasn't of the same order as that
seen here. With hyaluronidase, this has been
demonstrated previously by Forbes et al.
(Forbes, G., Deisher, H. W., Perley, A. M., and
Hartmann, A. F.: Effects of Hyaluronidase on the
Subcutaneous Absorption of Electrolytes in
Human Science 111: 177, 1950).
